Methods and compositions comprising desmopressin in combination with a beta-3-adrenergic receptor agonist
US10568927B2 · kind B2 · utility
0Cited by
25References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 13, 2017 |
| Grant date | Feb 25, 2020 |
| Priority date | — |
| Expiry date | Nov 13, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P13/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides methods and compositions for use of desmopressin in combination with a beta-3-adrenergic receptor agonist. The methods and compositions are useful in the treatment of nocturia and other urinary frequency disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.